María P. Roberti

4.2k total citations
10 papers, 312 citations indexed

About

María P. Roberti is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, María P. Roberti has authored 10 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in María P. Roberti's work include Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (2 papers). María P. Roberti is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer Immunotherapy and Biomarkers (4 papers) and CAR-T cell therapy research (2 papers). María P. Roberti collaborates with scholars based in Argentina, United States and Italy. María P. Roberti's co-authors include José Mordoh, Estrella Mariel Levy, Yamila Rocca, Michele Bianchini, Juan Martín Arriaga, Mora Amat, M. Betina Pampena, Alicia Bravo, Eduardo Huertas and Fernando Sánchez Loria and has published in prestigious journals such as Cancer Research, Frontiers in Immunology and European Journal of Immunology.

In The Last Decade

María P. Roberti

10 papers receiving 308 citations

Peers

María P. Roberti
Andrew Baessler United States
Carmine Menna United States
Yamila Rocca Argentina
Marit J van Elsas Netherlands
Aliyah M. Weinstein United States
Sandra Vogt United States
Arturo Villanueva United States
María P. Roberti
Citations per year, relative to María P. Roberti María P. Roberti (= 1×) peers Nela Klein-González

Countries citing papers authored by María P. Roberti

Since Specialization
Citations

This map shows the geographic impact of María P. Roberti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María P. Roberti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María P. Roberti more than expected).

Fields of papers citing papers by María P. Roberti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María P. Roberti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María P. Roberti. The network helps show where María P. Roberti may publish in the future.

Co-authorship network of co-authors of María P. Roberti

This figure shows the co-authorship network connecting the top 25 collaborators of María P. Roberti. A scholar is included among the top collaborators of María P. Roberti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María P. Roberti. María P. Roberti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Charoentong, Pornpimol, Inka Zoernig, María P. Roberti, et al.. (2025). MA04.06 Neoadjuvant Pembrolizumab: Multi-Omics Characterization of the Tumoral Immune Response Reveals Distinct Mechanisms of Action. Journal of Thoracic Oncology. 20(10). S68–S68. 1 indexed citations
2.
Roberti, María P., Yamila Rocca, Mora Amat, et al.. (2015). Overexpression of CD85j in TNBC patients inhibits Cetuximab‐mediated NK‐cell ADCC but can be restored with CD85j functional blockade. European Journal of Immunology. 45(5). 1560–1569. 41 indexed citations
3.
Arriaga, Juan Martín, Fernando Sánchez Loria, Eduardo Huertas, et al.. (2012). Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer. Human Pathology. 43(10). 1695–1703. 12 indexed citations
4.
Roberti, María P., José Mordoh, & Estrella Mariel Levy. (2012). Biological role of NK cells and immunotherapeutic approaches in breast cancer. Frontiers in Immunology. 3. 375–375. 38 indexed citations
5.
Roberti, María P., Yamila Rocca, Mora Amat, et al.. (2012). IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients. Breast Cancer Research and Treatment. 136(3). 659–671. 48 indexed citations
6.
Quesada‐Allué, Luis A., María P. Roberti, Jean‐Luc Teillaud, et al.. (2012). High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function. Cancer Immunology Immunotherapy. 62(1). 3–15. 4 indexed citations
7.
Roberti, María P., Juan Martín Arriaga, Michele Bianchini, et al.. (2012). Abstract 3393: Antibody-based array proteomics identify proteins differentially expressed in human metastatic and non-metastatic triple negative breast cancer cells. Cancer Research. 72(8_Supplement). 3393–3393. 1 indexed citations
8.
Rocca, Yamila, María P. Roberti, Juan Martín Arriaga, et al.. (2012). Altered phenotype in peripheral blood and tumor-associated NK cells from colorectal cancer patients. Innate Immunity. 19(1). 76–85. 116 indexed citations
9.
Roberti, María P., Alicia Bravo, Yamila Rocca, et al.. (2011). IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR. Breast Cancer Research and Treatment. 130(2). 465–475. 42 indexed citations
10.
Roberti, María P., Cecilia Surace, M. Cristina Digilio, et al.. (2011). Complex chromosome rearrangements related 15q14 microdeletion plays a relevant role in phenotype expression and delineates a novel recurrent syndrome. Orphanet Journal of Rare Diseases. 6(1). 17–17. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026